Naltrexone Hydrochloride + Bupropion Hydrochloride Er Tablets Suppliers & Bulk Manufacturers
Available Forms: ER tablets
Available Strengths: 8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride
Reference Brands: Contrave(US & EU)
Category:
Weight Loss drugs
Naltrexone hydrochloride combined with bupropion hydrochloride ER tablets suppress appetite by reducing cravings and affecting reward pathways in the brain. The combo supports weight loss, improves metabolic health, and reduces hunger. Benefits include appetite control, decreased food cravings, better weight management, and enhanced overall metabolic and psychological well-being.
naltrexone hydrochloride + bupropion hydrochloride ER tablets is available in ER tablets
and strengths such as 8 mg naltrexone hydrochloride / 90 mg bupropion hydrochloride.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, naltrexone hydrochloride + bupropion hydrochloride ER tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
naltrexone hydrochloride + bupropion hydrochloride ER tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Naltrexone hydrochloride and bupropion hydrochloride ER tablets are approved in the US by the FDA and in the EU via EMA for weight management. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For dossier preparation, regulatory pathways, and market access guidance, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability, helping individuals worldwide achieve effective weight loss, appetite control, and metabolic health through high-quality combination therapy supported by regional regulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing